Japan Gifts N3.6 Billion in Road Equipment to Nigeria

The central administration has obtained N3.6 billion worth of building machinery provided by the Japanese authorities.

In a press release, the Ministry of Works stated that the machinery provided to the Federal Roads Maintenance Agency (FERMA) would mark a significant step forward in the country’s efforts toward achieving sustainable infrastructure development.

The declaration, signed by the Ministry’s Director of Press, Mohammed Ahmed, cited the Minister of State for Works, Bello Muhammad Goronyo, Esq., who stated that “the generous support from Japan moves forward the dream of seamless, secure, and dependable transportation throughout the nation.”

Goronyo stated that roads serve as the vital arteries of Nigeria’s economy and everyday activities, with the machinery marking a significant advancement in their use and maintenance.

Worthed at £3.6 billion (three billion, six hundred million Nigerian naira), the provided machinery is anticipated to enhance FERMA’s ability to repair and restore Nigeria’s extensive highway system.

Goronyo highlighted that the contribution marks the beginning of a new phase in road upkeep, allowing engineers and technical staff to achieve quicker and longer-lasting results.

He further pointed out that Nigeria’s large highway system still plays a crucial role in trade, farming, medical services, and uniting the country, despite ongoing serious upkeep issues.

He also praised the actions of President Bola Ahmed Tinubu GCFR, who has placed infrastructure at the forefront and positioned it as a major factor in driving economic development through his Renewed Hope Agenda — a government that acknowledges infrastructure as a catalyst for progress.

“We imagine a future where traveling within Nigeria is smooth, safe, and reliable. This kind gesture brings us nearer to turning that dream into truth,” he added.

The President and citizens of Nigeria expressed deep appreciation through Goronyo to the Japanese government for its concrete assistance and steadfast dedication towards Nigeria’s progress.

He called on the management of FERMA and their engineering staff to guarantee that the machinery is utilized to the best of its potential, stating, “This equipment represents a significant resource, and its proper application will demonstrate our dedication to enhancing the standard of living for every Nigerian.”

He ended by pointing out that the installation of the machinery goes beyond a symbolic transfer, representing instead the start of a fresh phase in road upkeep that corresponds with Nigeria’s larger aim of achieving economic growth through improved infrastructure.

Supplied by SyndiGate Media Inc. (
Syndigate.info
).

African Development Bank Considers $500M Plan to Boost Funding for Smallholder Farmers

The African Development Bank Group President, Dr. Akinwumi Adesina, has unveiled plans to establish a $500 million fund aimed at unlocking up to $10 billion in financial support for small-scale farmers and small agricultural businesses throughout Africa.

At the High-Level Conference on Scaling Finance for Smallholder Farmers held in Nairobi, Adesina disclosed that the Bank’s leadership is actively engaging with its Board of Directors to set up this innovative funding mechanism.

The facility will utilize various financial tools such as trade credit guarantees, first-loss coverage, blended finance approaches, and origination incentives to lower the elevated transaction costs associated with servicing businesses. This effort will be supported by providing technical assistance.

“We are at the cusp of making history through our efforts to push the limits of innovation and form broad collaborative partnerships aimed at addressing the funding shortfall faced by small-scale farmers and agricultural businesses,” stated Adesina during his keynote speech.

Co-organized alongside the Pan-African Farmers’ Organization (PAFO), this conference aimed at tackling Africa’s significant $75 billion yearly funding shortfall faced by farmers and agribusinesses.

Adesina,
who has been granted Kenya’s top national distinction lately
As stated by President William Ruto–there is an urgent call for worldwide efforts: “Let us join hands to unlock the power of agriculture across Africa. Our aim should be to transform Africa into the world’s granary. Together, let’s nourish our continent with pride!”


Advancements Since the Dakar 2 Feed Africa Summit

Adesina pointed out significant advancements made since the 2023 Dakar Feed Africa Summit, during which 34 African leaders pledged their commitment to enhancing food security and sovereignty.

Development partners’ financial pledges have skyrocketed from their original commitment of $30 billion to an impressive $72 billion within just one year. In this effort, the African Development Bank alone committed $10 billion. To date, the bank has greenlit 77 initiatives totaling $3.9 billion aimed at supporting the execution of Country Food and Agriculture Delivery Compacts in 32 nations. Furthermore, they plan to approve another $1.72 billion before the end of this year for these endeavors.


Major programs aiding small-scale farmers

The Bank has initiated numerous key programs to bolster smallholder farmers:
1.
2.
(The numbered list format was not originally present but added as per instruction since the original text did not contain any specific points.)

The TAAT program has extended advanced, climate-adaptive crop varieties to 25 million farmers across Africa, thereby increasing the continent’s agricultural output by 120 million tons.

The $1.5 billion African Emergency Food Production Facility has distributed 459,000 tons of seeds and 2.8 million tons of fertilizers to 12.3 million farmers, resulting in the production of 37.6 million metric tons of food.

The Special Agro-Industrial Processing Zones program has committed $934.51 million, supplemented by $938.27 million in co-financing, aiding 27 initiatives across 11 nations.

The AFAWA initiative has granted $2.52 billion in financing to support 24,000 enterprises owned by women across Africa.

The African Fertilizer Financing Mechanism has introduced trade credit guarantees across nine nations, delivering 125,193 metric tons of fertilizer valued at $62.8 million to 776,971 small-scale farmers.

The Input Suppliers Risk Sharing Initiative, a $600 million program, aims to mitigate risks within the input supply chain across Uganda, Kenya, Tanzania, Ghana, and Zambia.

The MADE Alliance Africa, working alongside Mastercard, has secured a commitment of $300 million from the Bank to incorporate 3 million farmers across Kenya, Tanzania, and Nigeria into the digital economy.


Addressing persistent challenges

At present, merely 6% of African smallholder farmers can obtain credit, and fewer than 20% utilize enhanced seeds. Lenders frequently view these farmers as risky clients because of unpredictable weather patterns and insufficient security assets. The agricultural sector receives minimal bank loans, constituting under 5% of overall loan portfolios across numerous African nations, even though farming significantly impacts their economies.

“Some of you might recognize these figures; however, the rest of us ought to find them disheartening. It’s crucial that we take action immediately to alter this situation,” emphasized Dr. Beth Dunford, Vice President for Agriculture, Human, and Social Development at the Bank, during her address at the inaugural session on Monday.

PAFO President Ibrahima Coulibaly called upon all parties involved to act decisively, stating: “Should we wish to rescue our continent from hunger, malnutrition, and poverty, it is imperative that we generate employment opportunities within the agricultural sector. No other industry has the potential to accomplish this.”

The Kenyan Cabinet Secretary for Agriculture and Livestock Development, Senator Mutahi Kagwe, urged immediate action saying, “By focusing on innovative and feasible strategies, we can revamp agriculture as a profitable venture. We must ensure that not a single farmer is excluded from this progress because they lack financial resources.”

On Tuesday, a group of prominent international and African financial specialists likewise made a strong appeal to synchronize financial systems with the requirements of small-scale farmers. They emphasized the vital function of governments in fostering an atmosphere where financial institutions can increase their loans for agriculture.

Click
here
To view additional photographs from the Scaling Finance for Smallholder Farmers Conference.

Provided by SyndiGate Media Inc.
Syndigate.info
).

Innovative Tech Aid: Driving Global Impact Through International Cooperation [International Edition]

During the current Finance in Common Summit held in Cape Town, AfDB Vice President for Private Sector, Infrastructure & Industrialization, Solomon Quaynor, urged for an acceleration in the creation of viable green infrastructure initiatives. He highlighted the importance of scaling up these efforts, stressing that Africa must not be able to tolerate infrastructural development processes stretching over decades.

Addressing a session entitled

Cutting-Edge Technical Support: Closing Africa’s Infrastructure Divide,

Quaynor asserted that Africa needs to close its infrastructure gap by focusing on preparing and developing green infrastructure projects, making sure that both public and private sector tools are utilized efficiently. He highlighted that advancements in the future depend on:
1. Prioritizing the preparation of green infrastructure projects.
2. Developing these green infrastructure initiatives effectively.
3. Leveraging both public and private sector resources appropriately.

  • establishing a competitive marketplace for viable infrastructural projects
  • Speeding up the completion of successful green infrastructure projects from 10 years to just 3 years
  • Strengthening infrastructure development and asset managers like Africa50, as well as scalable green infrastructure project development platforms such as the Alliance for Green Infrastructure in Africa (AGIA) to mobilize large-scale investments.

Given Africa’s substantial needs for investment to close infrastructural and industrialization divides, the gathering delved into ways development finance institutions (DFIs), international collaborators, state-owned developmental banks, charities, and businesses could utilize technical support (TS) to foster enduring economic change. Presenters emphasized that TS should serve as more than just an initial spark; it must be designed to boost private-sector engagement and improve the efficiency of developmental funding efforts.

Quaynor emphasized that technical assistance should also be designed to de-risk investments and create the necessary enabling environment for private capital mobilization.

He said, “Innovative tools for technical assistance enable us to fill funding shortages, enhance organizational strength, and speed up the execution of groundbreaking initiatives. It’s crucial to reconsider our approach to deploying TA so that it results in lasting and expansive investment successes.”

The African Development Bank combines tools from both the public and private sectors to adopt a solution-driven strategy for developing infrastructure projects. Addressing Africa’s infrastructure deficit requires simultaneous focus on preparing and advancing projects, since insufficient viable initiatives continue to be a significant hurdle. Additionally, governments should spearhead efforts to create an atmosphere conducive to private-sector involvement to prevent exclusive claims by private investors. Both efficiency and high standards are crucial.

“Africa cannot continue with infrastructure projects that take between 7 to 10 years to develop—we need to speed up progress and complete them within 3 years, with an emphasis on sustainable green initiatives,” stated Quaynor.

AGIA (Alliance for Green Infrastructure in Africa), an innovative program launched by the African Development Bank in collaboration with Africa50 and the African Union Commission, aims to empower local builders with essential abilities, financing, and backing from seasoned infrastructural experts to expedite eco-friendly infrastructure growth. This effort centers on fostering a competitive arena where projects can thrive, enhancing rivalry, size, and velocity, thereby expanding the roster of triumphant environmentally friendly infrastructures. Through integrated planning and execution, programs such as AGIA are catalyzing large-scale, viable, and sustainable answers tailored for Africa’s upcoming needs.

One major point from the conversation emphasized the significance of tailoring technical aid to meet the requirements of both governmental bodies and private sector investors. Through an emphasis on enhancing capabilities, implementing regulatory changes, and preparing projects adequately, such support can boost the viability of initiatives and open up additional financing avenues. Additionally, attendees examined ways in which digital tools and collaborative online resources could increase the effectiveness and outcomes of these assistance efforts.

As the AfDB remains dedicated to promoting Africa’s economic progress, Quaynor emphasized the organization’s pledge to cultivate collaborations that stimulate innovation in technical support. The bank is currently collaborating with various development partners to deploy this technical assistance effectively, aligning these efforts with the bank’s overarching goals as outlined in its High 5 priorities—especially focusing on industrialization and incorporating infrastructure development initiatives.

The Finance in Common Summit acts as an essential forum for enhancing cooperation between public development banks and financial organizations. During this year’s meetings in Cape Town, there has been a focus on the necessity of adopting innovative methods for providing technical aid. These strategies aim to do more than just back standalone initiatives; they seek to drive broad-scale transformation within Africa’s financial and investment ecosystems.

Provided by SyndiGate Media Inc.
Syndigate.info
).

Trump Cuts Funding for Critical HIV and TB Research in South Africa

Letters canceling funding, which abruptly halts millions of rand worth of HIV and TB research grants funded by the U.S. government at South African universities, began circulating over the weekend. One impacted researcher predicts that more than 300 such grants could be terminated by the end of Sunday, potentially leading to significant consequences for higher education and research institutions, including substantial job cuts.

Certain specialists approximate that as high as 70% of South Africa’s medical research, equivalent to between $400 million (approximately R7.2 billion) including both primary and subsidiary grants from the previous fiscal year, receives funding via the National Institutes of Health (NIH). The NIH comprises various components.
27 institutes and centres
Each one concentrates on a particular field of study. The NIH funds roughly seventy-five percent of global biomedical research.

On Friday night, the University of the Witwatersrand’s
Wits Health Consortium
The unit responsible for managing the institution’s clinical trials and donor-funded initiatives has received termination notices for all aspects of a $2.5 million (approximately R460 million) grant, which concludes in November 2027. This particular grant was provided via the NIH.
National Institutes of Allergy and Infectious Diseases
.

Letters of cancellation, issued on behalf of the chief grants management officer at USAID, Emily Linde, appear to follow a standardized format informing researchers that their projects “fail to contribute to our understanding of living systems, yield minimal returns on investment, and do not improve health outcomes, longevity, or disease reduction.” The letters also allege that these research efforts negatively impact “the well-being of Americans.”

The Wits project was conducted.
by lead researchers Helen Rees, who heads the
Wits Reproductive Health Institute
, with Ian Sanne, leading the Clinical HIV Research Unit, who is now also involved with an international development organization,
Palladium
as its
chief medical officer
.

Paradoxically, our grant concluded on Human Rights Day, a time dedicated to assisting and protecting those in need. Yet now, the U.S. government is compelling us to act contrary to these principles,” Sanne explained to Bhekisisa. “Abruptly halting study volunteer participation could place them in danger. Does this align with global ethical standards for humans?

The study, ongoing since 2007, came under the
The Wits Research Group Clinical Trials Unit,
and carried out research on HIV and TB prevention and treatment, along with clinical trials for hepatitis and HIV-associated cancers.


Letters of termination were received on Human Rights Day

Other grants that have apparently been terminated up until now encompass research initiatives at the
Center for AIDS Research Program in South Africa
, Caprisa,
headed up
By Salim and Quarraisha Abdool Karim.

Several South African universities, which received sub-grants for health research from American institutions like Columbia University in New York, received cease operations directives on Friday following the loss of funding by the U.S.-based grantors. At present, these South African entities wish to remain unnamed.

Science magazine
reports
The ex-leader of the South African Medical Research Council, Glenda Gray was informed that her $3.1 million (approximately R56.5 million) grant for a clinical trials unit in Soweto [operating via Wits] has shifted from an approved to a pending status.

The
Center for AIDS Research Program in South Africa
, Caprisa,
headed up
By Salim and Quarraisha Abdool Karim, who receive substantial funding from the NIH, is currently on high alert. “So far, we haven’t gotten any notifications of terminated NIH grants. However, we anticipate receiving them soon,” Salim Abdool Karim informed Bhekisisa on Sunday morning.


TB funding ends as the US confronts TB outbreaks.

Throughout the years, certain HIV prevention research conducted within Sanne’s and Rees’s initiative has focused on populations more susceptible to HIV infection, including adolescent girls and young women in Africa, transgender individuals, and female sex workers.

The cancellation email mentioned that their “award no longer aligns with agency goals” and noted that “research programs focused mainly on arbitrary and nonscientific criteria, such as vague equity aims, go against genuine scientific exploration, fail to broaden our understanding of living systems, yield minimal benefits from investments, and ultimately do not improve health outcomes, extend lifespan, or decrease illnesses.”

Worst of all, the note said, “so-called diversity, equity, and inclusion (“DEI”) studies are often used to support unlawful discrimination on the basis of race and other protected characteristics, which harms the health of Americans. Therefore, it is the policy of NIH not to prioritise such research programmes.

The mentions of diversity, equity, and inclusion in the letter probably pertain to the work conducted at Wits regarding transgender individuals and women involved in sex work—topics that the Trump administration disapproves of.

On the evening of his inauguration, which took place on January 20, the president
signed an executive order
banning people’s right to identify as transgender or non-binary individuals. There are only two genders, the executive order declared: male and female.

However, Sanne argues that the mentions of DEI in their letter are not relevant because even though some of their studies have centered around marginalized communities like transgender individuals and sex workers, much of their efforts are directed towards developing efficient treatments for pediatricTB and improving medications for those suffering from multi-drug resistant TB, along with focusing on preventative measures against TB.

Indeed, our efforts align perfectly with President Trump’s vision of ‘making America great.’ We enhance national safety, fortify economic strength, and boost prosperity by safeguarding Americans from tuberculosis. Furthermore, much of the patent rights and intellectual property for the novel medications we evaluate belong to U.S.-based firms.


Experts weigh in

Linda-Gail Bekner, who leads the Desmond Tutu Health Foundation at the University of Cape Town and also receives support from the NIH, cautions that this further setback to our clinical research sector occurs when new tuberculosis infections are ”
have reached their peak levels in many years within the USA
“.

Kansas is presently experiencing the biggest tuberculosis outbreak that the United States has witnessed in this period.
past 30-40 years
(TB is a condition that has been well-managed in the U.S. for many years.) More than
60TB of data related to disease cases, along with two fatalities, have been reported.
.

By Saturday, Bekker hadn’t gotten a cancellation letter for her grant, yet she states: “Reducing the impact of HIV and TB so they no longer pose a major public health risk is crucial globally. South Africa has taken considerable steps and made important contributions toward achieving this objective.”

Yogan Pillay, who leads HIV and TB initiatives at the Gates Foundation—a organization that also supports HIV andTB research—expresses concern over potential U.S. government funding reductions. He states, “These budget cuts could halt progress in developing new prevention methods and treatments for HIV. As a result, eradicating AIDS may remain an unattainable vision, with HIV continuing to proliferate.”

“It’s absolutely tragic.”


Trump: “No corrective action is possible here”

The Wits initiative conducted significant TB research. One
study
Published in February and featured on the NIH website, this study examined the effectiveness of double doses of the antiretroviral medication dolutegravir in treating tuberculosis patients.

Previous trials looked at
How secure was it for expectant mothers with HIV to use preventative tuberculosis medication?
, regarding the effectiveness of long-acting, injectable formulations of antiretroviral therapy
worked for teens
And how effective the bi-monthly HIV injection is
worked
.

Sanne says “it is inconceivable that [Elon Musk’s so-called] department of government efficiency [which is leading cuts on US government spending], does not understand that there is more than just DEI activities happening through HIV and other research”.

The email stated: “While NIH typically opts for suspension rather than immediate termination of a grant, providing the recipient a chance to implement necessary corrections prior to a potential termination decision, such corrective actions cannot be undertaken in this case.”

This award’s objective is not aligned with our agency’s priorities, and no changes to the project can bring it in line with these priorities.


Terminations not unexpected

However, the termination of the grants was not unforeseen — or at least not since last week.

On March 12,
Science magazine reported
Matthew Memoli, who was serving as the acting director of the NIH, requested officials at the institute to gather lists of grants related to South Africa. The content of this email mirrored the phrasing used in previous NIH inquiries that resulted in the cancellation of numerous grants focusing on areas such as transgender health, vaccine hesitance, and other subjects not endorsed by the administration.

At least
300 US university projects
have also had their grants revoked by the Trump administration, with many being US universities.
resulting in demonstrations throughout the United States
.

These terminations are part of the measures that the Trump administration views as cost-saving efforts or research that doesn’t align with their beliefs, and such actions are expected to keep occurring globally.

SA researchers have initiated discussions with charitable organizations and the government to provide financial support, according to Sanne, who adds that “there haven’t been definite results yet.”

Projects in South Africa that received cancellation notices were informed that they had the option to “contest and submit evidence refuting” their termination decisions.

However, they must initially go through a “first-level grant appeal process” which needs to be completed before they can proceed to “submit an appeal to the departmental appeals board.”

If projects decide to contest, they must file an appeal within 30 days of receiving their termination notices.

Sanne mentions his intention to utilize the appeals process, and if that proves unfruitful, at minimum, seek negotiations for an ethical and responsible termination of the trials. He elaborates: “Our research is crucial for saving lives, and the NIH has supported us in this endeavor. What we must now strive to achieve is convincing them of our work’s significance instead of ending decades of investment which could lead to lost lives.”

The Gates Foundation is referenced in this piece. Although Bhekisisa receives financial support from the Foundation, it maintains its independence in editorial matters.

This narrative was created by the
Bhekisisa Center for Health Journalism
. Register for the
newsletter
.

Provided by SyndiGate Media Inc.
Syndigate.info
).

Trump Halts U.S. Funding for Critical HIV and TB Research in South Africa

Letters canceling funding, which abruptly halts millions of rand worth of HIV and TB research grants sponsored by the U.S. government at South African universities, began arriving over the weekend. According to an impacted researcher, it’s expected that more than 300 such grants will be terminated by the end of Sunday. This situation has significant repercussions for higher education and research institutions, including substantial job cuts.

Certain specialists approximate that around 70% of South Africa’s medical research funding, equivalent to approximately $400 million (roughly R7.2 billion) including both primary and subsidiary grants from the previous fiscal year, originates from the National Institutes of Health (NIH). The NIH comprises numerous components supporting this significant contribution.
27 institutes and centres
Each initiative targets a particular field of study. The NIH funds roughly seventy-five percent of global biomedical research.

On Friday night, the University of the Witwatersrand hosted an event.
Wits Health Consortium
The unit responsible for managing the institution’s clinical trials and donor-funded initiatives has received termination notices for all parts of a $2.5 million (approximately R460 million) grant, which concludes in November 2027. This particular grant was provided via the NIH.
National Institutes of Allergy and Infectious Diseases
.

Letters canceling funding, issued on behalf of the chief grants management officer at USAID, Emily Linde, appear to follow a typical format. These letters inform researchers that their projects “fail to advance understanding of biological processes, yield minimal financial benefits, and do not improve public well-being, longevity, or disease reduction.” Additionally, they suggest these initiatives may negatively impact “the wellbeing of American citizens.”

The Wits project was conducted
by lead researchers Helen Rees, who heads the
Wits Reproductive Health Institute
, with Ian Sanne leading the Clinical HIV Research Unit and now also contributing to the international development organization,
Palladium
as its
chief medical officer
.

Ironically, our grant concluded on Human Rights Day, a time meant for aiding and protecting those who are most susceptible,” Sanne said to Bhekisisa. “Now, however, the U.S. government is compelling us to act contrary to these principles. Abruptly halting study participation could place trial volunteers in harm’s way. Does this align with global ethical standards for human research?

The study, ongoing since 2007, came under the
The Wits Research Group Clinical Trials Unit,
and carried out HIV and TB prevention and treatment studies, along with clinical trials for hepatitis and HIV-associated cancers.


Letters of termination were received on Human Rights Day

Other grants that have apparently been terminated up until now encompass research initiatives at the
Center for AIDS Research Program in South Africa
, Caprisa,
headed up
by Salim and Quarraisha Abdool Karim

Several South African universities, which received sub-grants for health research from U.S. institutions like Columbia University in New York, received cease-and-desist directives on Friday following the loss of funding by the American entities. At present, these South African organizations wish to remain unnamed.

Science magazine
reports
The ex-leader of the South African Medical Research Council, Glenda Gray was informed that her $3.1 million (approximately R56.5 million) grant for a clinical trial unit in Soweto [operated via Wits] has shifted from an approved to a pending status.

The
Center for AIDS Research Program in South Africa
, Caprisa,
headed up
By Salim and Quarraisha Abdool Karim, who receive substantial funding from the NIH, is currently on high alert. “So far, we haven’t gotten any notices of termination for our NIH grants,” said Salim Abdool Karim to Bhekisisa early Sunday morning.


TB funding ends as the US confronts TB outbreaks.

Throughout the years, certain HIV prevention research conducted within Sanne’s and Rees’s initiative has focused on populations more susceptible to contracting HIV. These include adolescent girls and young women in Africa, transgender individuals, and female sex workers.

The cancellation email mentioned that their “award no longer aligns with agency goals” and noted that “research programs focused mainly on artificial and nonscientific criteria, such as vague equity aims, go against scientific exploration, fail to broaden our understanding of living organisms, yield minimal benefits for investments made, and ultimately do not improve health outcomes, extend lifespan, or decrease illnesses.”

Worst of all, the note said, “so-called diversity, equity, and inclusion (“DEI”) studies are often used to support unlawful discrimination on the basis of race and other protected characteristics, which harms the health of Americans. Therefore, it is the policy of NIH not to prioritise such research programmes.

The allusions in the letter to diversity, equity, and inclusion probably pertain to the work conducted at Wits regarding transgender individuals and female sex workers—categories of people disapproved of by the Trump administration.

On the evening of his inauguration, which took place on January 20, the president
signed an executive order
banning people’s right to identify as transgender or non-binary individuals. There are only two genders, the executive order declared: male and female.

However, Sanne argues that the mentions of DEI in their letter are not logical. Despite having conducted some studies on communities like transgender individuals and sex workers, much of their work centers around developing efficient treatments for pediatric tuberculosis and improving medications for those with multi-drug resistant TB, along with focusing on preventative measures against TB.

In numerous aspects, our work aligns perfectly with President Trump’s vision of ‘making America great.’ It enhances American safety, strength, and prosperity by safeguarding citizens from tuberculosis-related illnesses. Moreover, a significant portion of the patents and intellectual property for the novel medications we evaluate belong to U.S.-based firms.

SUBHEAD: Experts weigh in

Linda-Gail Bekner, who leads the Desmond Tutu Health Foundation at the University of Cape Town and also obtains NIH funding, cautions that this further setback to our clinical research sector occurs when new TB infections are ”
are at their peak levels in many years within the USA
”.

Kansas is presently experiencing the biggest tuberculosis outbreak that the United States has witnessed in this period.
past 30-40 years
(TB is a condition that has been well-managed in the U.S. for many years.) Furthermore,
60TB of data related to disease cases, along with two fatalities, have been reported.
.

By Saturday, Bekker hadn’t gotten a cancellation letter regarding her grant, yet she states: “Reducing the impact of HIV and TB epidemics to the point where they no longer pose a major public health risk is a matter of worldwide importance. South Africa has taken considerable steps and made notable contributions toward advancing this cause.”

Yogan Pillay, who leads HIV and TB initiatives at the Gates Foundation – an organization that also supports HIV andTB research and stands to be affected by U.S. government budget reductions – cautions: “These cuts will halt progress in both prevention and treatment of HIV. As a result, eradicating or even controlling AIDS has become nothing more than an illusion, with HIV continuing to proliferate.”

“It’s absolutely tragic.”


Trump stated, “Corrective action cannot be taken here.”

The Wits project conducted significant TB research. One
study
Published in February and featured on the NIH website, this study examined the effectiveness of administering double doses of the antiretroviral medication dolutegravir in TB patients.

Previous trials looked at
How secure was it for expectant mothers with HIV to use preventative tuberculosis medication?
, at how effective long-acting, injectable versions of antiretroviral therapy are
worked for teens
And how effective this bi-monthly HIV injection is
worked
.

Sanne states, “It’s unimaginable that [the alleged] Elon Musk-led governmental office for efficiency doesn’t grasp that there is more going on beyond merely DEI initiatives through HIV and various other research endeavors.”

The email stated: “While NIH typically opts for suspending (instead of outright terminating) a grant and provides the recipient a chance to undertake necessary corrective actions prior to making a final termination decision, such measures cannot be taken in this instance.”

The essence of this award is at odds with the agency’s goals, and no changes to the project would bring it in line with these priorities.


Terminations not unexpected

However, the termination of the grants was not unforeseen — or at least not since last week.

On March 12,
Science magazine reported
Matthew Memoli, who was serving as the acting director of the NIH, requested officials at the institute to assemble lists of grants related to South Africa. This email mirrored the phrasing used in previous NIH inquiries that resulted in the cancellation of numerous grants focused on areas such as transgender health, vaccine hesitance, and others not supported by the current administration.

At least
300 US university projects
have also had their grants revoked by the Trump administration, with numerous institutions being US universities.
resulting in demonstrations throughout the United States
.

These terminations are part of what the Trump administration views as cost-saving measures or research that doesn’t align with their beliefs, and such cuts are expected to keep happening globally.

SA researchers have initiated discussions with philanthropic foundations and the government to provide financial support, according to Sanne, who notes that “there haven’t been definite results” yet.

Projects in South Africa that received cancellation notices were informed that they had the opportunity to “contest and submit data and documents refuting” their termination decisions.

However, they must initially go through a “first-level grant appeal process” which needs to be completed before they can proceed to “file an appeal with the departmental appeals board.”

If projects decide to contest the decision, they must file an appeal within 30 days of receiving their termination notice.

Sanne mentions his intention to utilize the appeals process, and should those efforts not succeed, he aims to negotiate an ethical and responsible method for terminating the trials. “Our research saves lives, and the NIH has supported us in this endeavor,” he states. “Now, what we must do is persuade them of the importance of continuing our work instead of ending decades of investment which could lead to the loss of many lives.”

The Gates Foundation is referenced in this piece. Although Bhekisisa receives financial support from the Foundation, it maintains its independence in editing and content decisions.

This tale was crafted by the
Bhekisisa Center for Health Journalism
. Register for the
newsletter
.

Provided by Syndigate Media Inc. (
Syndigate.info
).